AstraZeneca
Cambridge · Founded 1913
About AstraZeneca
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. It discovers new medicines that are designed to improve the health and quality of life of patients, offering added benefits such as reduced side effects or better ways of taking the treatment. It focuses on getting the best from every medicine it makes by exploring all the ways it can be used or improved.
Company Facts
- Founded: 1913
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $7.3B
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2026)
- Ticker: lse:AZN
- Website: https://www.astrazeneca.com
- Phone: +44 20 3749 5000
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Investment Activity
- 13 exit(s) (11 via IPO)
Social Profiles
Canonical: https://fsome.com/organization/astrazeneca-56361 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.